Troponin I vs Troponin T
Direct answer: Troponin I (cTnI) and troponin T (cTnT) are both cardiac-specific markers released when heart muscle is damaged; either is used to diagnose acute myocardial infarction. They are roughly equivalent diagnostically, with minor assay-specific differences.
Comparison table
| Troponin I (cTnI) | Troponin T (cTnT) | |
|---|---|---|
| Source | Cardiac muscle | Cardiac muscle (small skeletal expression) |
| Rise | ~3–6 h after injury | ~3–6 h after injury |
| Peak | ~12–24 h | ~12–48 h |
| Use | MI diagnosis (POC + lab) | MI diagnosis (primarily lab) |
What each marker is
- cTnI: cardiac-specific troponin I — the most common target for point-of-care rapid tests.
- cTnT: cardiac troponin T — widely used in high-sensitivity laboratory assays.
Strengths
- Both are cardiac-specific and central to MI diagnosis; cTnI is more common in rapid POC formats.
Limitations
- Both rise in non-MI conditions (renal failure, myocarditis); serial testing and clinical context are required.
- POC qualitative troponin is triage-grade — high-sensitivity lab assays are the standard.
False positive / negative considerations
- False negative: testing too early (before the ~3–6 h rise).
- False positive: non-MI causes of troponin elevation.
Confirmatory testing
Serial high-sensitivity troponin measurement and ECG are standard; a single POC result is a triage aid, not a diagnosis.
Procurement considerations
Hospitals buy cardiac panels (troponin + CK-MB + myoglobin + D-dimer) rather than single markers.
Related pages
Which test to choose
Either is diagnostically equivalent for myocardial infarction; cTnI is more common in point-of-care rapid formats, while cTnT dominates high-sensitivity laboratory assays.
Last reviewed: 2026-09-12